These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6464744)

  • 21. [Neonatal cystic fibrosis screening program in the state of Paraná: evaluation 30 months after implementation].
    Santos GP; Domingos MT; Wittig EO; Riedi CA; Rosário NA
    J Pediatr (Rio J); 2005; 81(3):240-4. PubMed ID: 15951909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucoviscidosis screening with immunoreactive trypsin. Initial experiences in Austria].
    Eber E; Zach M; Engele H; Haas J; Pürstner P; Mutz I; Litscher H
    Monatsschr Kinderheilkd; 1992 Jul; 140(7):411-5. PubMed ID: 1501616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cystic fibrosis among newborns in Norway by measurement of serum/plasma trypsin-like immunoreactivity. Results of a 2 1/2-year pilot project.
    Edminson PD; Michalsen H; Aagenaes O; Lie SO
    Scand J Gastroenterol Suppl; 1988; 143():13-8. PubMed ID: 3164498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    Hammond KB; Abman SH; Sokol RJ; Accurso FJ
    N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactive trypsin screening for cystic fibrosis.
    Borgström A; Sveger T; Lindberg T; Kollberg H; Larsson A
    Acta Paediatr Scand; 1982 Jul; 71(4):621-4. PubMed ID: 7136678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new strategy of neonatal screening for cystic fibrosis. The association of immunoreactive trypsin and molecular biology in dried blood].
    Laroche D; Peres O; Briard ML; Lemonnier F; Pasquet-Ferre C; Blandin C; Travert G; Fernandez Y
    Arch Fr Pediatr; 1990 Apr; 47(4):251-3. PubMed ID: 2363611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen.
    Wesley AW; Smith PA; Elliott RB
    Aust Paediatr J; 1989 Jun; 25(3):151-5. PubMed ID: 2764837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
    Ranieri E; Lewis BD; Gerace RL; Ryall RG; Morris CP; Nelson PV; Carey WF; Robertson EF
    BMJ; 1994 Jun; 308(6942):1469-72. PubMed ID: 8019280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of pancreatic function in screened infants with cystic fibrosis.
    Gaskin K; Waters D; Dorney S; Gruca M; O'Halloran M; Wilcken B
    Pediatr Pulmonol Suppl; 1991; 7():69-71. PubMed ID: 1782134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results].
    Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J
    Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.
    Chatfield S; Owen G; Ryley HC; Williams J; Alfaham M; Goodchild MC; Weller P
    Arch Dis Child; 1991 Jan; 66(1 Spec No):29-33. PubMed ID: 1996888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mucoviscidosis screening by determination of immunoreactive trypsin].
    Sander J; Niehaus C
    Klin Padiatr; 1984; 196(4):224-7. PubMed ID: 6482307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactive trypsin in blood from foetuses and preterm infants.
    Borgström A; Lindberg T; Sveger T; Kullander S; Svanberg L
    Acta Paediatr Scand; 1982 Sep; 71(5):849-50. PubMed ID: 7180458
    [No Abstract]   [Full Text] [Related]  

  • 37. Dried blood spot immunoreactive trypsin (IRT) values.
    Pederzini F; Mastella G; Giglio L; Faraguna D
    Eur J Pediatr; 1988 Aug; 147(6):663. PubMed ID: 3181210
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoreactive trypsin in the serum of normal children and children with gastrointestinal diseases].
    Dockter G; Steyns M; Biro G; Sitzmann FC
    Monatsschr Kinderheilkd; 1984 Aug; 132(8):589-93. PubMed ID: 6482880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity.
    Castellani C; Bonizzato A; Cabrini G; Mastella G
    Acta Paediatr; 1997 May; 86(5):497-502. PubMed ID: 9183489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.